業績
武城 英明| 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
| 原著論文| 総説/著書| 国際会議 |
原著論文
Yokoyama S‚ Yamashita S‚ Ishibashi S‚ Sone H‚ Oikawa S‚ Shirai K‚ Ohta T‚ Bujo H‚ Kobayashi J‚ Arai H‚ Harada-Shiba M‚ Eto M‚ Hayashi T‚ Gotoda T‚ Suzuki H‚ Yamada N. Background to discuss guidelines for control of plasma HDL-cholesterol in Japan.
J Atheroscler Thromb. 2012; 19 (3): 207-212
Guo LH‚ Westerteicher C‚ Wang XH‚ Kratzer M‚ Tsolakidou A‚ Jiang M‚ Grimmer T‚ Laws SM‚ Alexopoulos P‚ Bujo H‚ Kurz A‚ Perneczky R. SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.
Eur Arch Psychiatry Clin Neurosci. 2012; in press
Fukaya Y‚ Kuroda M‚ Aoyagi Y‚ Asada S‚ Kubota Y‚ Okamoto Y‚ Nakayama T‚ Saito Y‚ Satoh K‚ Bujo H. Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system.
Exp Mol Med. 2012; 44 (5): 330-339
Takahashi M‚ Bujo H‚ Shiba T‚ Jiang M‚ Maeno T‚ Shirai K. Enhanced Circulating Soluble LR11 in Patients With Diabetic Retinopathy.
Am J Ophthalmol. 2012; 154 (1): 187-192
Aoyagi‚ Y.‚ Kuroda‚ M.‚ Asada‚ S.‚ Tanaka‚ S.‚ Konno‚ S‚. Tanio‚ M.‚ Aso‚ M.‚ Okamoto‚ Y.‚ Nakayama‚ T.‚ Saito‚ Y.‚ Bujo‚ H. Fibrin glue is a candidate scaffold for long-term therapeutic protein expression in spontaneously differentiated adipocytes in vitro.
Exp Cell Res. 2012; 318 (1): 8-15
Alexopoulos P‚ Guo LH‚ Tsolakidou A‚ Kratzer M‚ Grimmer T‚ Westerteicher C‚ Jiang M‚ Bujo H‚ Diehl-Schmid J‚ Kurz A‚ Perneczky R. Interrelations between CSF Soluble AβPPβ‚ Amyloid-β 1-42‚ SORL1‚ and Tau Levels in Alzheimer’s Disease.
J Alzheimers Dis. 2012; 28 (3): 543-552
Gotoda T‚ Shirai K‚ Ohta T‚ Kobayashi J‚ Yokoyama S‚ Oikawa S‚ Bujo H‚ Ishibashi S‚ Arai H‚ Yamashita S‚ Harada-Shiba M‚ Eto M‚ Hayashi T‚ Sone H‚ Suzuki H‚ Yamada N. Diagnosis and Management of Type I and Type V Hyperlipoproteinemia.
J Atheroscler Thromb. 2012; 19 (1): 1-12
Arai H‚ Ishibashi S‚ Bujo H‚ Hayashi T‚ Yokoyama S‚ Oikawa S‚ Kobayashi J‚ Shirai K‚ Ota T‚ Yamashita S‚ Gotoda T‚ Harada-Shiba M‚ Sone H‚ Eto M‚ Suzuki H‚ Yamada N. Management of Type IIb Dyslipidemia.
J Atheroscler Thromb. 2012; 19 (2): 105-114
総説/著書
黒田正幸，武城英明 脂質異常症の遺伝子治療 カレントテラピー（株式会社ライフメディコム） 2012; 30 (3): 264-265
国際会議
Ikeuchi T‚ Hirayama S‚ Miida T‚ Tokutake T‚ Yajima R‚ Jiang M‚ Bujo H‚ Nishizawa M Quantification of soluble LR11/SorLA in CSF and plasma of patients with Alzheimer disease
Keystone Symposia - ApoE‚ Alzheimer’s‚ and lipoprotein biology 2012-2-23 Keystone/USA
Watanabe K‚ Suzuki H‚ Haniu H‚ Numano F‚ Saitoh A‚ Uchiyama M‚ Bujo H Soluble LR 11: a novel biomarker for vascular lesion development late after Kawasaki disease
The 10th International Kawasaki Disease Symposium 2012-2-16 Kyoto/Japan
